Repligen Sweden AB

ABActive

Org 5568690704Sankt Lars Väg 47, 222 70 LundManufacture of basic pharmaceutical products· NACE 2110Est. 2011 · 14 years old100-199 employees

Overview Financials People & ownership Related companies

Repligen Sweden AB is a Swedish AB based in Lund, operating in the Manufacture of basic pharmaceutical products sector. Incorporated in 2011, the company reported revenue of SEK 587,7M in its latest annual filing.

Revenue 2024

SEK 587,7M

-31% vs 2023

EBITDA margin

71.6%

-28% vs 2023

Net profit 2024

SEK 488,2M

-9% vs 2023

Key ratios

See full ratios →

64.0%

This company

20202024

7.4×

This company

20202024

14.5%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 587,7M	-31%
EBITDA	SEK 420,6M	-28%
Net profit	SEK 488,2M	-9%
Total assets	SEK 3,4B	+32%
Equity	SEK 2,2B	+29%
Employees	—	—

Contact

Address

Sankt Lars Väg 47, 222 70 Lund

Phone

+46709289894

gusi@repligen.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Repligen Sweden AB?

Repligen Sweden AB is registered with Bolagsverket / SCB under Org 5568690704.

What is the revenue of Repligen Sweden AB?

Repligen Sweden AB reported revenue of SEK 587,7M in 2024.

Who is the chairman of Repligen Sweden AB?

James Richard Bylund chairs the board of Repligen Sweden AB, in role since 2025.

Where is Repligen Sweden AB headquartered?

Repligen Sweden AB's registered address is Sankt Lars Väg 47.

Repligen Sweden AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Repligen Sweden AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Repligen Sweden AB